AI Biomed PredictionsTNYA – ASGCT TN-401 data could decide Tenaya’s next sharp rerating ScanScor Admin / May 2, 2026
AI Biomed PredictionsPYPD – PolyPid Nears NDA Completion With Regulatory Repricing Potential ScanScor Admin / May 2, 2026
AI Biomed PredictionsPRQR – AX-0810 Human Proof-of-Mechanism Could Reprice ProQR Quickly ScanScor Admin / May 2, 2026
AI Biomed PredictionsOSTX – OSTX Faces Its Defining FDA Pathway Test This Month ScanScor Admin / May 2, 2026
AI Biomed PredictionsOBIO – HRS AVIM data could spark OBIO’s next revaluation ScanScor Admin / May 2, 2026
AI Biomed PredictionsINO – Depressed Inovio May Rebound on FDA Review Reassurance ScanScor Admin / May 2, 2026
AI Biomed PredictionsADAG – Next ADAG move likely hinges on execution, not hype ScanScor Admin / May 2, 2026
AI Biomed PredictionsACXP – Microcap ACXP hinges on proof ibezapolstat development is truly starting ScanScor Admin / May 2, 2026
AI Biomed PredictionsGANX – GANX Faces a Crucial May Test for Parkinson’s Repricing ScanScor Admin / May 2, 2026
AI Biomed PredictionsMGNX – Mid-2026 data could decide MacroGenics’ turnaround trajectory ScanScor Admin / May 2, 2026
